UK Research Material Regulation and Advertising Monitor
Source check: 23 October 2026. This entry records changes stated on the official MHRA borderline-products page and the implications that still require review for Knockout Labs. It does not announce a new law or determine the status of a catalogue product.
What the official update log says
| Official date | Recorded change | Interpretation limit |
|---|---|---|
| 12 May 2026 | Guidance Note 8 replaced with a slightly amended version | The log alone does not identify every substantive change |
| 2 July 2026 | Complaints statistics updated for November 2025–April 2026 | A statistics update is not itself a new classification rule |
Both entries are stated in the official page history. [2]
The currently linked Guidance Note 8 carries a September 2025 cover publication date and notes that appendices may have different update dates. Its filename should not be treated as the authoritative publication date. [1]
What this check establishes
The current official source and its update history have been identified. No line-by-line comparison with the superseded document is claimed. It would therefore be premature to attribute a specific newly introduced requirement to the May replacement solely from the update note.
Site-impact review to complete
| Review item | Required decision |
|---|---|
| Source version | Record the exact document reviewed and date |
| Product identity | Confirm the entity each decision covers |
| Presentation | Review descriptions, imagery, categories and linked content together |
| Changes required | Identify exact content or supply changes, if any |
| Responsibility | Name the qualified reviewer and business decision owner |
| Follow-up | Establish an actual review trigger or routine |
The classification policy and website-presentation explainer provide the relevant site context. This dated source record is complete; the qualified impact decision and an ongoing monitoring process remain outstanding.
Supporting checks
| Resource | Why open it |
|---|---|
| Research Use and Buyer Eligibility Policy | Read the UK research-buyer and manual-order-review conditions. |
| Claims We Do Not Make | Check the site’s stated limits on claims and intended use. |
| Compliance | Find the policy owner for eligibility, classification or claims. |
Sources and scope
- MHRA Guidance Note 8: A guide to what is a medicinal productCase-by-case classification; presentation context; cover date distinct from file name Access: Official source opened; relevant passage read Limits: Not a definitive statement of law or product-specific decision; no qualified review claimed
- MHRA: Borderline products: how to tell if your product is a medicine12 May 2026 guidance replacement; 2 July 2026 statistics update; assessment factors Access: Official source opened; relevant passage read Limits: No claim that an update note proves a new law or exact substantive amendment